↓ Skip to main content
What is this page? Embed badge

Adult cancer survivors: How are they faring?

Overview of attention for article published in Cancer (0008543X), January 2005
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

policy
1 policy source
guideline
1 clinical guideline source

Readers on

mendeley
180 Mendeley
So far, Altmetric has seen 1 policy document that references this research output.

Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer: Ovarian cancer - topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent disease only (Review of TA 91

Cited by National Institute for Health and Care Excellence (NICE) on

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.